Agnieszka Graczyk-Jarzynka

The Great War of Today: Modifications of CAR-T Cells to Effectively Combat Malignancies

M. Winiarska, A. Graczyk-Jarzynka, A. Zhylko, 2020, Cancers.

Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax

J. Gołąb, T. Milne, W. Młynarski, 2022, Oncogene.

Harnessing altered oxidative metabolism in cancer by augmented prooxidant therapy.

R. Zagożdżon, M. Firczuk, Agnieszka Góral, 2019, Cancer letters.

PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress

Dariusz M Plewczynski, D. Plewczyński, M. Lazniewski, 2021, Cancer Immunology Research.

Comparison of DNA Methylation and Expression Pattern of S100 and Other Epidermal Differentiation Complex Genes in Differentiating Keratinocytes

W. Leśniak, A. Graczyk-Jarzynka, Barbara Sobiak, 2016, Journal of cellular biochemistry.

Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies

M. Mikuła, D. Nowis, J. Gołąb, 2021, Cancer Research.

HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies.

M. Słabicki, J. Gołąb, B. Pyrzyńska, 2017, Blood.

Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer

R. Zagożdżon, Z. Pilch, A. Graczyk-Jarzynka, 2019, Cancers.